Objective: Cesarean delivery (CD) is a known risk factor for postpartum hemorrhage. However, the characteristics associated with post-CD transfusion are not well-established. We aimed to assess blood transfusion rates and associated factors following CD.

Methods: A retrospective case-control study of women who underwent CD at a university hospital. The study group comprised all women who received blood transfusion following surgery. A control group of women who did not receive postoperative blood transfusion was assigned in a two-to-one ratio.

Results: During study period, the overall post-CD blood transfusion rate was 4.7%. The study group comprised 170 women, and the control group 340. Maternal age (aOR [95% CI]: 1.07 (1.03, 1.11),  = .001), parity (aOR [95% CI]: 1.26 (1.09, 1.47),  = .002), gestational hypertensive disorders (aOR [95% CI]: 4.07 (1.52, 10.91),  = .005), maternal comorbidities (aOR [95% CI]: 4.16 (1.88, 9.1),  < .001), lower predelivery hemoglobin level (aOR [95% CI]: 0.43 (0.34, 0.54),  < .001), and major placental abnormalities (aOR [95% CI]: 2.74 (1.04, 7.18),  = .04) were independently associated with blood transfusion requirement. Intrapartum characteristics associated with blood transfusion requirement included nonelective procedure (aOR [95% CI]: 3.21 (1.72, 5.99),  < .001), prolonged second stage of labor (aOR [95% CI]: 5.50 (2.57, 11.78),  < .001), longer duration of surgery (aOR [95% CI]: 1.03 (1.02, 1.04),  < .001), general anesthesia (aOR [95% CI]: 2.11 (1.14, 3.91),  = .02), and greater estimated operative blood loss (aOR [95% CI]: 5.72 (3.15, 10.36),  < .001).

Conclusions: Among women who underwent CD, we identified 11 factors associated with blood transfusion following surgery. Prospective studies are warranted to assess the implementations of prophylactic interventions to reduce transfusion rates among those deemed at high risk for CD-related bleeding.

Download full-text PDF

Source
http://dx.doi.org/10.1080/14767058.2020.1724945DOI Listing

Publication Analysis

Top Keywords

blood transfusion
20
aor [95%
16
[95% ci]
16
study group
8
group comprised
8
control group
8
transfusion
6
blood
5
study
5
factors associated
4

Similar Publications

Introduction In idiopathic scoliosis surgery, studies have shown two attending surgeons have better curve correction, pain, and recovery time. There is conflicting evidence on operative time, blood loss, infection rate, and hospital length of stay. Limited literature examines the impact of surgeon experience on the dual approach.

View Article and Find Full Text PDF

Background: Pelvic fractures often result in traumatic and intraoperative blood loss. Cell salvage (CS) is a tool where autologous blood lost during surgery is collected and recycled with anticoagulation, centrifugation to separate red blood cells, and washing to be reinfused back to the patient. The purpose of this study was to investigate our experience with CS in pelvic and acetabular surgery and its relationship to perioperative transfusion requirements.

View Article and Find Full Text PDF

Background: Neonates with congenital anomalies frequently require perioperative allogeneic red blood cell (RBC) transfusion. Whole cord blood for autologous transfusion to neonates may provide an alternative RBC source, but whether sufficient volumes can be collected after delayed cord clamping to reduce allogeneic RBC requirements is unknown.

Study Design And Methods: Inclusion criteria were mothers delivering a viable infant >34 weeks' gestation.

View Article and Find Full Text PDF

Apheresis is essential to conducting hematopoietic cell transplantation and genetically engineered cellular therapy procedures. Many patients and donors require central venous catheter (CVC) access for apheresis due to lack of adequate peripheral venous access. CVC placement has risks of associated complications and requires additional institutional resources and expertise.

View Article and Find Full Text PDF

Objective: To observe the clinical efficacy of TPO receptor agonists and platelet transfusion in chemotherapy-induced thrombocytopenia in malignant tumors.

Methods: Clinical data from 120 patients with malignant tumors who developed thrombocytopenia following chemotherapy at our hospital were retrospectively collected and randomly divided into three groups: A, B, and C, with 40 patients in each group. Group A was treated with a TPO receptor agonist (avatrombopag), group B received autologous platelet transfusion, and group C received a combination of both treatments.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!